{"name": "Trillium Therapeutics",
 "permalink": "trillium-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/trillium-therapeutics",
 "homepage_url": "http://www.trilliumtherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@trilliumtherapeutics.com",
 "phone_number": "416-595-0627",
 "description": "",
 "created_at": "Fri May 13 03:19:09 UTC 2011",
 "updated_at": "Fri May 13 03:19:08 UTC 2011",
 "overview": "\u003Cp\u003ETrillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation. The company specializes in the discovery and development of protein therapeutics, such as monoclonal antibodies, secreted proteins, and peptides. It involves in therapeutic areas, including autoimmune disease, cancer, necrotizing enterocolitis, and transplantation. Trillium Therapeutics Inc. was formerly known as Transplantation Technologies Inc. and changed its name in May 2003. The company was founded in 1996 and is based in Toronto, Canada.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       54],
      "assets/images/resized/0013/4438/134438v1-max-150x150.png"],
     [[174,
       63],
      "assets/images/resized/0013/4438/134438v1-max-250x250.png"],
     [[174,
       63],
      "assets/images/resized/0013/4438/134438v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Niclas",
      "last_name": "Stiernholm",
      "permalink": "niclas-stiernholm",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.trilliumtherapeutics.com/pdf/IC_final.pdf",
    "source_description": "Trillium raises funds to advance urology program into clinical trials",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 12,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "96 Skyway Ave.",
    "address2": "",
    "zip_code": "M9W 4Y9",
    "city": "Toronto, ON",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}